Daewoong pharmaceutical Co.,Ltd (069620.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 2T |
| Enterprise Value | 2.66T |
| P/E Ratio | 6.67 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0.84 |
| Price/Book Ratio | 1.31 |
| Enterprise/Revenue | 1.3 |
| Enterprise/EBITDA | 8.88 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.13 |
| Operating Margin | 0.11 |
| Return On Assets | 0.08 |
| Return On Equity | 0.21 |
| Revenue | 1.57T |
| Revenue/Share | 137,412.12 |
| Gross Profit | 812.85B |
| EBITDA | 245.78B |
| Net Income | 195.86B |
| Diluted EPS | 17,021 |
| Total Cash | 168.03B |
| Total Cash/Share | 14,501.66 |
| Total Debt | 900.43B |
| Total Debt/Equity | 0.88 |
| Current Ratio | 1.12 |
| Book Value Per Share | 99,613.57 |
| 52-Week Change | -23.67 |
| 52-Week High | 199,400 |
| 52-Week Low | 113,300 |
| Moving Average 50 Days | 137,500 |
| Moving Average 200 Days | 154,648.5 |
| Average Volume | 33,432 |
| Shares Outstanding | 11.51M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 600 |
| Trailing Annual Dividend Yield | 0.52 |
| Payout Ratio | 0.05 |
| Last Split Factor | 103:100 |
| Last Split Date | December 27, 2012 |